REGENXBIO Inc. Diluted Shares Outstanding (Weighted Average)
REGENXBIO Inc. (RGNX) reported Diluted Shares Outstanding (Weighted Average) of 53.02 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- REGENXBIO Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 53.02M shares, a 2.98% increase year-over-year.
- REGENXBIO Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 52.43M shares, a 1.93% increase year-over-year.
- REGENXBIO Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 51.75M shares, a 1.71% increase year-over-year.
- REGENXBIO Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 51.69M shares, a 1.75% increase year-over-year.
- REGENXBIO Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 51.57M shares, a 4.17% increase from fiscal 2024.
- REGENXBIO Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 49.51M shares, a 13.20% increase from fiscal 2023.
- REGENXBIO Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 43.73M shares, a 1.35% increase from fiscal 2022.
- REGENXBIO Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 43.15M shares, a 1.73% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 53.02M shares 10-Q · filed 2026-08-06 | 52.63M shares 10-Q · filed 2026-08-06 | 52.40M shares derived: average of 3 quarters · filed 2026-08-06 | 52.22M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | 52.43M shares 10-Q · filed 2026-05-14 | 52.09M shares derived: average of 2 quarters · filed 2026-05-14 | 51.96M shares derived: average of 3 quarters · filed 2026-05-14 | 51.84M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | 51.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 51.72M shares derived: average of 2 quarters · filed 2026-03-05 | 51.64M shares derived: average of 3 quarters · filed 2026-08-06 | 51.57M shares 10-K · filed 2026-03-05 | |||
| 2025-09-30 | 51.69M shares 10-Q · filed 2025-11-06 | 51.59M shares derived: average of 2 quarters · filed 2026-08-06 | 51.51M shares 10-Q · filed 2025-11-06 | 51.37M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | 51.48M shares 10-Q · filed 2026-08-06 | 51.42M shares 10-Q · filed 2026-08-06 | 51.27M shares derived: average of 3 quarters · filed 2026-08-06 | 51.15M shares derived: average of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | 51.43M shares 10-Q · filed 2026-05-14 | 51.16M shares derived: average of 2 quarters · filed 2026-05-14 | 51.04M shares derived: average of 3 quarters · filed 2026-05-14 | 50.93M shares derived: average of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | 50.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 50.84M shares derived: average of 2 quarters · filed 2026-03-05 | 50.76M shares derived: average of 3 quarters · filed 2026-03-05 | 49.51M shares 10-K · filed 2026-03-05 | |||
| 2024-09-30 | 50.80M shares 10-Q · filed 2025-11-06 | 50.70M shares derived: average of 2 quarters · filed 2025-11-06 | 49.05M shares 10-Q · filed 2025-11-06 | 47.78M shares derived: average of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | 50.60M shares 10-Q · filed 2025-08-07 | 48.17M shares 10-Q · filed 2025-08-07 | 46.78M shares derived: average of 3 quarters · filed 2025-08-07 | 46.07M shares derived: average of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | 45.73M shares 10-Q · filed 2025-05-12 | 44.87M shares derived: average of 2 quarters · filed 2025-05-12 | 44.56M shares derived: average of 3 quarters · filed 2025-05-12 | 44.30M shares derived: average of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | 44.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 43.97M shares derived: average of 2 quarters · filed 2025-03-13 | 43.83M shares derived: average of 3 quarters · filed 2025-03-13 | 43.73M shares 10-K · filed 2025-03-13 | |||
| 2023-09-30 | 43.95M shares 10-Q · filed 2024-11-06 | 43.95K shares 10-Q · filed 2023-11-08 | 43.74M shares derived: average of 2 quarters · filed 2024-11-06 | 43.64M shares 10-Q · filed 2024-11-06 | 43.64K shares 10-Q · filed 2023-11-08 | 75.85M shares derived: average of 4 quarters · filed 2025-03-13 | |
| 2023-06-30 | 43.53M shares 10-Q · filed 2024-08-01 | 43.53K shares 10-Q · filed 2023-08-02 | 43.49M shares 10-Q · filed 2024-08-01 | 43.49K shares 10-Q · filed 2023-08-02 | 86.49M shares derived: average of 3 quarters · filed 2025-03-13 | 64.88M shares derived: average of 4 quarters · filed 2025-03-13 | |
| 2023-03-31 | 43.45M shares 10-Q · filed 2024-05-08 | 43.45K shares 10-Q · filed 2023-05-03 | 107.96M shares derived: average of 2 quarters · filed 2025-03-13 | 71.99M shares derived: average of 3 quarters · filed 2025-03-13 | 54.00M shares derived: average of 4 quarters · filed 2025-03-13 | ||
| 2022-12-31 | 172.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 86.26M shares derived: average of 2 quarters · filed 2025-03-13 | 57.52M shares derived: average of 3 quarters · filed 2025-03-13 | 43.15M shares 10-K · filed 2025-03-13 | |||
| 2022-09-30 | 43.25K shares 10-Q · filed 2023-11-08 | 43.18K shares derived: average of 2 quarters · filed 2023-11-08 | 43.10K shares 10-Q · filed 2023-11-08 | 43.91M shares derived: average of 4 quarters · filed 2024-02-27 | |||
| 2022-06-30 | 43.11K shares 10-Q · filed 2023-08-02 | 43.03K shares 10-Q · filed 2023-08-02 | 58.54M shares derived: average of 3 quarters · filed 2024-02-27 | 43.91M shares derived: average of 4 quarters · filed 2024-02-27 | |||
| 2022-03-31 | 42.94K shares 10-Q · filed 2023-05-03 | 87.78M shares derived: average of 2 quarters · filed 2024-02-27 | 58.54M shares derived: average of 3 quarters · filed 2024-02-27 | 43.91M shares derived: average of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | 175.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 87.78M shares derived: average of 2 quarters · filed 2024-02-27 | 58.54M shares derived: average of 3 quarters · filed 2024-02-27 | 43.91M shares 10-K · filed 2024-02-27 | |||
| 2021-09-30 | 42.63K shares 10-Q · filed 2022-11-03 | 42.63M shares 10-Q · filed 2021-11-02 | 42.57K shares derived: average of 2 quarters · filed 2022-11-03 | 42.32K shares 10-Q · filed 2022-11-03 | 42.32M shares 10-Q · filed 2021-11-02 | ||
| 2021-06-30 | 42.51K shares 10-Q · filed 2022-08-03 | 42.17K shares 10-Q · filed 2022-08-03 | |||||
| 2020-12-31 | 37.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 38.15M shares derived: average of 2 quarters · filed 2023-02-28 | 37.28M shares 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | 38.88M shares 10-Q · filed 2021-11-02 | 37.23M shares 10-Q · filed 2021-11-02 | |||||
| 2019-12-31 | 36.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 36.86M shares derived: average of 2 quarters · filed 2022-03-01 | 36.80M shares derived: average of 3 quarters · filed 2022-03-01 | 36.69M shares 10-K · filed 2022-03-01 | |||
| 2019-09-30 | 36.81M shares 10-Q · filed 2020-11-04 | 36.74M shares derived: average of 2 quarters · filed 2020-11-04 | 36.62M shares 10-Q · filed 2020-11-04 | 37.20M shares derived: average of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | 36.67M shares 10-Q · filed 2019-08-07 | 36.52M shares 10-Q · filed 2019-08-07 | 37.33M shares derived: average of 3 quarters · filed 2021-03-01 | 36.50M shares derived: average of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | 36.37M shares 10-Q · filed 2019-05-07 | 37.67M shares derived: average of 2 quarters · filed 2021-03-01 | 36.44M shares derived: average of 3 quarters · filed 2021-03-01 | 36.15M shares derived: average of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | 38.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 36.48M shares derived: average of 2 quarters · filed 2021-03-01 | 36.08M shares derived: average of 3 quarters · filed 2021-03-01 | 36.65M shares 10-K · filed 2021-03-01 | |||
| 2018-09-30 | 33.99M shares 10-Q · filed 2019-11-05 | 34.63M shares derived: average of 2 quarters · filed 2019-11-05 | 35.88M shares 10-Q · filed 2019-11-05 | 33.68M shares derived: average of 4 quarters · filed 2020-02-26 | |||
| 2018-06-30 | 35.27M shares 10-Q · filed 2019-08-07 | 34.88M shares 10-Q · filed 2019-08-07 | 33.58M shares derived: average of 3 quarters · filed 2020-02-26 | 32.92M shares derived: average of 4 quarters · filed 2020-02-26 | |||
| 2018-03-31 | 34.27M shares 10-Q · filed 2019-05-07 | 32.73M shares derived: average of 2 quarters · filed 2020-02-26 | 32.14M shares derived: average of 3 quarters · filed 2020-02-26 | 31.77M shares derived: average of 4 quarters · filed 2020-02-26 | |||
| 2017-12-31 | 31.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | 31.07M shares derived: average of 2 quarters · filed 2020-02-26 | 30.93M shares derived: average of 3 quarters · filed 2020-02-26 | 29.88M shares 10-K · filed 2020-02-26 | |||
| 2017-09-30 | 30.94M shares 10-Q · filed 2018-11-07 | 30.80M shares derived: average of 2 quarters · filed 2018-11-07 | 29.44M shares 10-Q · filed 2018-11-07 | ||||
| 2017-06-30 | 30.66M shares 10-Q · filed 2018-08-08 | 28.68M shares 10-Q · filed 2018-08-08 | |||||
| 2017-03-31 | 26.67M shares 10-Q · filed 2018-05-08 | ||||||
| 2016-12-31 | 26.41M shares 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |